Drug recall D-0437-2026

Class II Ongoing reported Apr 15, 2026

Product

5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.

Reason for recall

Lack of Assurance of Sterility

Lots and codes

Batch# 6402165, Exp Date: 05/30/2028.

Recall details

Recalling firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Distribution
US Nationwide , Alaska, and Puerto Rico.
Type
Voluntary: Firm initiated
Recall initiated
March 11, 2026

Related products